Skip to main content
Study: Few youths with cancer receive precision medicine

Fifty-one percent of 223 children with cancer could have been treated with precision medicine calibrated for certain mutations, but only 7% were given treatment, even though precision medicine may be more beneficial in youths than in adults, according to a study in the European Journal of Cancer. Researchers attributed the low use in childhood cancers to the response of some children to standard treatments, as well as a lack of pediatric trials evaluating drugs that proved effective among adults.

Full Story: